期刊文献+

基于临床护理路径的冠心病合并Ⅱ型糖尿病介入治疗效果及对生活质量的影响 被引量:46

Effect of Clinical Nursing Pathway on the Treatment Effect and Quality of Life of Patients with Coronary Heart Disease Complicated with Type Ⅱ Diabetes Intervention
原文传递
导出
摘要 为了全面评估临床护理路径对冠心病合并Ⅱ型糖尿病介入治疗效果及对生活质量的影响,本研究选择84例冠心病合并Ⅱ型糖尿病介入治疗患者作为研究对象,按照计算机随机数字表法分为对照组和试验组,每组42例,对照组给予常规护理,试验组给予临床护理路径护理,比较早期活动能力、住院时间和费用、生活质量评分及并发症情况。经分析比较发现:试验组患者的开始床上活动时间和床下活动时间短于对照组,而术后24 h的6 min步行距离和出院前1 d的12 min步行距离等明显高于对照组(p<0.01)。试验组住院时间和住院费用明显低于对照组(p<0.01)。试验组生活质量的躯体功能、认知功能、情绪功能、角色功能和社会功能等评分均高于对照组(p<0.05)。试验组心律失常及并发症发生率明显低于对照组(p<0.05)。对冠心病合并Ⅱ型糖尿病介入患者进行临床护理路径干预措施,利于患者早期活动,减少住院时间和费用,提高生活质量,降低并发症发生率。 In order to comprehensively evaluate the effect of clinical nursing pathway on the treatment effect and quality of life of patients with coronary heart disease complicated with type Ⅱ diabetes intervention, 84 patients with coronary heart disease complicated with type Ⅱ diabetes interventional therapy were selected as object in this research, who were divided into the control group and the treatment group with 42 cases in each group according to random number table method. The control group was given routine nursing care, while the treatment group was given nursing care of clinical nursing pathway, and the early activity capacity, hospital time and costs, score of quality of life and complications of the two groups were compared. The result of analysis and comparison showed that the time to start bed activity and the time to get out of bed of the treatment group were shorter than those of the control group, and the walking distance in 6 min 24 h after operation and the walking distance in 12 min 1 d before leaving the hospital of the treatment group were obviously longer than those of the control group (p 〈0.01). In addition, the hospital time and costs of the treatment group were obviously lower than those of the control group (p 〈0.01). The scores of physical function, cognitive function, emotional function, role function and social function of the quality of life of the treatment group were higher than those of the control group (p〈0.05). The incidence ofarrhythmia and complications in the treatment group were significantly lower than those in the control group (P〈0.05). The intervention of clinical nursing pathway for patients with coronary heart disease complicated with type Ⅱ diabetes could be beneficial to patients for early activity, reduce hospital time and costs, improve the quality of life, and lower the incidence of complications.
作者 刘玉华 李丽
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2017年第8期3379-3383,共5页 Genomics and Applied Biology
基金 国家自然科学基金(81660429)资助
关键词 临床护理路经 冠心病 Ⅱ型糖尿 介入治疗 生活质量 Clinical nursing pathway, Coronary heart disease, Type Ⅱ diabetes, Interventional
作者简介 通讯作者,1534627936@qq.com
  • 相关文献

参考文献5

二级参考文献35

  • 1吴琪.血清尿酸对冠心病并糖尿病患者PCI术后再狭窄的影响[J].心血管康复医学杂志,2006,15(6):546-547. 被引量:3
  • 2Mills EJ,Wu P,Chong G, et al. Efficacy and safety of statin treat-ment for cardiovascular disease : a network meta-analysis of 170 255patients from 76 randomized trials [ J ]. QJM, 2011, 104 ( 2 ) ; 109-124.
  • 3Dotevall A, Hasdai D, Wallentin L, et al. Diabetes mellitus: clinicalpresentation and outcome in men and women with acute coronarysyndromes. Data from the Euro Heart Survey ACS[ J]. Diabet Med,2005,22(11):1542 -1550.
  • 4Echeverri D,Cabrales J. Statins and percutaneous coronary interven-tion :a complementary synergy [ J ]. Clin Investig Arlerioscler,2013 ,25(3) :112 -122.
  • 5Jaiswal M,Schinske A,Pop-Busui R. Lipids and lipid managementin diabetes [ J ] . Best Pract Res Clin Endocrinol Melab,2014,28(3):325 -338.
  • 6Roffi M,Topol EJ. Percutaneous coronary intervention in diabetic pa-tients with non-ST-segment elevation acute coronary syndromes [ J ].Eur Heart J,2004,25(3) : 190 - 198.
  • 7Kirn JA, Montagnani M, Koh KK, et al. Reciprocal relationships be-tween insulin resistance and endothelial dysfunction: molecular andpathophysiological mechanisms [ J ]. Circulation, 2006, 113 ( 15 ):1888 -1904.
  • 8Colbert JD, Stone JA. Statin use and the risk of incident diabetesmellitus ; a review of the literature [ J ] . Can J Cardiol ,2012 ,28 ( 5 ):581 -589.
  • 9Sampson UK, Linton MF, Fazio S. Are statins diabetogenic. [J].Curr Opin Cardiol,2011,26(4) :342 -347.
  • 10Culver AL,Ockene IS,Balasubramanian R,et al. Statin use and riskof diabetes mellitus in postmenopausal women in the Women; sHealth Initiative[ J]. Arch Intern Med,2012,172 (2) : 144 - 152.

共引文献53

同被引文献352

引证文献46

二级引证文献348

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部